Ethical considerations for discontinuing pacemakers and automatic implantable cardiac defibrillators at the end-of-life

Current Opinion in Anaesthesiology

Volumn 26, Issue 2, 2013, Pages 171-175

  Morgenweck, Cynthiane J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

deactivation; end of life; ethics; intracardiac devices

Indexed keywords

ARTIFICIAL HEART PACEMAKER; BIOETHICS; CLINICAL DECISION MAKING; HEALTH CARE POLICY; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; PALLIATIVE THERAPY; PATIENT DECISION MAKING; PATIENT EDUCATION; PATIENT PREFERENCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESUSCITATION; REVIEW; TERMINAL CARE; TERMINAL DISEASE; TREATMENT WITHDRAWAL;

DEFIBRILLATORS, IMPLANTABLE; HUMANS; PACEMAKER, ARTIFICIAL; RESUSCITATION ORDERS; TERMINAL CARE; WITHHOLDING TREATMENT;

EID: 84874947535     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0b013e32835e8349     Document Type: Review

References (26)

1. Lampert R, Hayes DL, Annas GJ, et al. HRS expert consensus statement on the management of cardiovascular implantable electronic devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm 2010; 7:1008-1026.
2. Padeletti L, Arnar DO, Boncinelli L, et al. EHRA expert consensus statement on the management of cardiovascular implantable electronic devices patients nearing end of life or requesting withdrawal of therapy. Europace 2010; 12:1480-1489.
3. Rady MY, Verheidje JL. When is deactivating an implanted cardiac device physician-assisted death? Appraisal of the letha pathophysiology and mode of death. J Palliat Med 2011; 14:1086-1088.
4. Magyar-Russell G, Thombs BD, Cai JX, et al. The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systemic review. J Psychosomatic Res 2011; 71:223-231.
5. Burns KM, Evans F, Kaltman JR. Pediatric ICD utilization in the United States from 1997 to 2006. Heart Rhythm 2011; 8:23-28.
6. Russo JE. Deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes. AJN 2011; 111:26-35.
7. Kramer DB, Kesselheim AS, Salberg L, et al. Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy. Am J Cardiol 2011; 107:1071-1075.
8. Kirkpatrick JN, Gottlieb M, Sehgal P, et al. Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care. Am J Cardiol 2012; 109:91-94.
9. Dodson JA, Fried T, Van Ness PH et al. Preferences for ICD deactivation in the setting of advanced illness, presentation at 2012 American Geriatrics Society annual meeting, slides. www.americangeriatrics.org [Accessed on 14 October 2012].
10. Strachan PH, Carroll SL, de Laat S, et al. Patients perspectives on end-of-life issues and implantable cardioverter defibrillators. J Palliat Care 2011; 27:6-11.
11. Raphael CE, Koa-Wing M, Stain J, et al. Implantable cardioverter- defibrillator recipient attitudes towards device deactivation: how much do patients want to know? PACE 2011; 34:1628-1633.
12. Kapa S, Mueller PS, Hayes DL, Asirvatham SJ. Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients. Mayo Clin Proc 2010; 85:981-990.
13. Matlock DD, Nowels CT, Masoudi FA, et al. Patient and cardiologists perceptions on decision making for implantable cardioverter-defibrillators: a qualitative study. PACE 2011; 34:1634-1644.
14. Caverly TJ, Al-Khatib SM, Kutner JS, et al. Patent preference in the decision to place implantable cardioverter-defibrillators. Arch Intern Med 2012; 172:1104-1105.
15. Kramer DB, Buxton AE, Simetbaum PJ. Time for a change: a new approach to ICD replacement. NEJM 2012; 366:291-293.
16. Fromme EK, Stewart TL, Jeppesen M, Tolle SW. Adverse experiences with implantable defibrillators in oregon hospices. Am J Hospice Palliat Med 2011; 28:304-309.
17. Lakshmanadoss U, Kulkarni A, Sherazi S, et al. Comparison of patterns of ICD deactivation in community hospice center vs hospice in an academic institution [abstract]. Circ: Cardiovas Qual Out 2012; 5:A284.
18. Goldberger ZD, Fagerlin A. ICDs: increasingly complex decisions. Arch Intern Med 2012; 172:1106-1107.
19. Dunbar SB, Dougherty CM, Sears SF, et al. Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from the American Heart Association. Circulation 2012; 126:2146-2172.
20. Singh B, Singh J. ICD's near end of life: risk versus benefit: a review. Am J Hospice 2012; 29:421-430.
21. Clark AM, Jaarsma T, Strachan P, et al. Effective communication and ethical consent in decisions related to ICDs. Nat Rev Cardiol 2011; 8:694-705.
22. Grubb BP, Karabin, Ethical dillemmas and end-of-life choices for patients with implantable cardiac devices: decisions regarding discontinuation of therapy. Curr Treatment Options in Cardiovasc Med 2011; 13:385-392.
23. Huddle TS, Bailey FA. Pacemaker deactivation: withdrawal of support or active ending of life. Theor Med Bioeth 2012; 33:421-433.
24. Whitlock SN, Goldberg IP, Singh JP. Is pacemaker deactivation at the end of life unique? a case study and ethical analysis. J Pall Med 2011; 14:1184-1188.
25. Kramer DB, Ottenberg AL, Gerhardson S, et al. 'Just because we can doesn't meanweshould': viewsofnursesondeactivationofpacemakersandimplantable cardioverter-defibrillators. J Interv Card Electrophysiol 2011; 32:243-252.
26. Mueller PS, Ottenberg AL, Hayes DL, Koenig BA. 'I felt like the angel of death': role conflicts and moral distress among allied professionals employed by the US cardiovascular implantable electronic device industry. J Interv Card Electrophysiol 2011; 32:253-261.